Objective: To study lipiodol deposition in portal vein tumour thrombus (PVTT) in predicting the treatment outcome of hepatocellular carcinoma (HCC) patients after transarterial chemoembolisation (TACE).

Methods: We retrospectively reviewed data from 379 HCC patients with PVTT who underwent TACE as the initial treatment at Sun Yat-Sen University Cancer Center from January 2008 to December 2015. Patients were grouped by positive and negative lipiodol deposition based on the extent of lipiodol deposition in PVTT. The overall survival (OS) and progression-free survival (PFS) were compared between negative and positive lipiodol deposition groups; furthermore, the value of the combinatorial evaluation of tumour responses and lipiodol deposition in PVTT in predicting prognosis was analysed in subgroup patients with stable disease (SD) after TACE.

Results: Of the 379 patients, 264 (69.7%) had negative and 115 (30.3%) had positive lipiodol deposition in PVTT after TACE. Multivariate analysis identified positive lipiodol deposition in PVTT as an independent prognostic factor for favourable OS (p = 0.001). The median OS and PFS of negative and positive lipiodol deposition groups were 4.70 vs. 8.97 months (p = 0.001) and 3.1 months vs. 5.8 months (p < 0.001). In subgroup patients, the median OS and PFS of negative and positive lipiodol deposition groups were 4.7 months vs. 10.5 months (p < 0.001) and 3.5 months vs. 7.0 months (p < 0.001), respectively.

Conclusions: The patients with positive lipiodol deposition in PVTT had a longer OS than those with negative lipiodol deposition. Furthermore, the positive lipiodol deposition in PVTT can further differentiate HCC patients with favourable prognosis from SD patients.

Key Points: • Lipiodol deposition in PVTT is a prognostic indicator for HCC patients after TACE treatment. • Positive lipiodol deposition in PVTT is associated with a better prognosis.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-019-06157-0DOI Listing

Publication Analysis

Top Keywords

lipiodol deposition
36
deposition pvtt
16
positive lipiodol
16
hcc patients
12
lipiodol
9
deposition portal
8
portal vein
8
vein tumour
8
tumour thrombus
8
treatment outcome
8

Similar Publications

An 80-year-old patient with hepatocellular carcinoma (HCC) underwent an 18 F-FDG PET/CT scan owing to suspected lumbar metastasis identified via a CT scan performed during transarterial chemoembolization (TACE) 2 weeks earlier. The PET scan revealed segmental high uptake in the HCC and surrounding liver parenchyma, where lipiodol deposited during TACE had mostly washed out. The segmental uptake was attributed to TACE-induced inflammatory changes in the liver parenchyma around the HCC, confirmed by reduced uptake in a follow-up 18 F-FDG PET/CT scan 4 months later.

View Article and Find Full Text PDF

Purpose: To create and evaluate prediction models of local tumor recurrence after successful conventional transcatheter arterial chemoembolization (c-TACE) via radiomics analysis of lipiodol deposition using cone-beam computed tomography (CBCT) images obtained at the completion of TACE.

Materials And Methods: A total of 103 hepatocellular carcinoma nodules in 71 patients, who achieved a complete response (CR) based on the modified Response Evaluation Criteria in Solid Tumors 1 month after TACE, were categorized into two groups: prolonged CR and recurrence groups. Three types of areas were segmented on CBCT: whole segment (WS), tumor segment (TS), and peritumor segment (PS).

View Article and Find Full Text PDF

Subarachnoid Intra-cranial Lipiodol Deposits.

Cureus

June 2024

Radiology, Hôpital de Braine-L'Alleud, Braine-L'Alleud, BEL.

Lipiodol, an oil-based contrast medium first introduced in 1944, was commonly used for various radiological exams until the 1980s, when it was replaced by water-soluble contrast media due to complications such as arachnoiditis and chronic irritations. Due to its slow resorption rate, asymptomatic lipiodol deposits can occasionally be found incidentally. This case report describes a 93-year-old man who presented to the emergency department after a fall.

View Article and Find Full Text PDF

Clinical impact and potential utility of non-enhanced computed tomography performed immediately after transarterial chemoembolization for hepatocellular carcinoma.

J Gastrointest Oncol

June 2024

Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.

Article Synopsis
  • The study investigates the role of immediate post-transarterial chemoembolization (TACE) non-enhanced computed tomography (NECT) in evaluating lipiodol uptake in hepatocellular carcinoma (HCC) patients, which may impact prognosis.
  • Out of 189 patients analyzed, those with incomplete lipiodol uptake (Cohort B) had significantly shorter time to progression (TTP) compared to those with complete uptake (Cohort C). Cohort A, which received additional treatment, showed no progression during follow-up.
  • The findings suggest that assessing lipiodol uptake through NECT can effectively stratify HCC patients and inform treatment adjustments based on their early response to TACE.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!